Fixative Stabilization for Dynamic Gene Expression Monitoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing gene expression are limited by the degradation of mRNA and the use of preservative compositions that cause irreversible damage to nucleic acids, making it difficult to obtain high-quality RNA for clinical and research purposes.

Innovation Solution

The method involves obtaining biological samples at multiple time points, stabilizing them using fixative agents like formaldehyde or alcohol to prevent degradation, and quantifying polynucleotides or polypeptides to determine changes indicative of mental, emotional, or physical states, using a system that includes a computer program for data analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If preservative compositions are used to maintain biological samples, then sample stability is improved, but nucleic acid quality deteriorates due to irreversible damage

Engineering Contradiction:
Improvesample stabilityVSAvoidnucleic acid quality
Core Design Contradiction:
Stability of the object's compositionVSManufacturing precision

Solution Approach 1:

The patent applies preliminary action by stabilizing biological samples immediately upon collection using fixative agents like formaldehyde or alcohol. This prevents mRNA degradation before analysis, allowing high-quality RNA to be obtained without requiring preservative compositions that would cause irreversible damage to nucleic acids.

Inventive Principle:
Principle #10Preliminary action

2Loss of information

If mRNA is extracted from biological samples for gene expression analysis, then gene expression data is obtained, but mRNA degradation occurs reducing analysis accuracy

Engineering Contradiction:
Improvegene expression dataVSAvoidanalysis accuracy
Core Design Contradiction:
Loss of informationVSReliability

Solution Approach 1:

The patent applies preliminary anti-action by using fixative agents to prevent mRNA degradation before extraction and analysis. This counteracts the natural degradation process, preserving mRNA integrity and ensuring accurate gene expression analysis without information loss.

Inventive Principle:
Principle #9Preliminary anti-action

3Measurement precision

If multiple time point sampling is performed for dynamic monitoring, then state change detection is improved, but sample collection complexity increases

Engineering Contradiction:
Improvestate change detectionVSAvoidsampling system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent uses fixative agents as intermediaries that can be applied to biological samples during routine collection procedures. This allows multiple time point sampling for dynamic monitoring without significantly increasing system complexity, as the fixative agents integrate seamlessly into existing sampling workflows while enabling precise state change detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the effective monitoring of mental, emotional, or physical states by preventing mRNA degradation and maintaining cellular integrity, enabling accurate gene expression analysis and providing a non-invasive, efficient means for disease diagnosis and prognosis.

Implementation Method 1

stabilizing them using fixative agents like formaldehyde or alcohol to prevent degradation

Methodology Applied
Scientific EffectFixation:

Data Source

PatentUS10280466B2Method and kit for dynamic gene expression monitoring
Publication Date: 2019.05.07 INSTITUTE OF NOETIC SCIENCES
  • US10280466B2 patent drawing
  • US10280466B2 patent drawing
  • US10280466B2 patent drawing

AI summary

This disclosure relates to methods and kits, systems for screening, diagnosing and prognosing a disease, disorder, or physiological state based upon temporal measurements and analysis of gene expression in a subject.